Rethinking drug discovery through transcription factor biology
Complex diseases rarely have single targets. By focusing on transcription…
Complex diseases rarely have single targets. By focusing on transcription factor activity and disease signatures, Scripta Therapeutics is taking a different approach to identifying the drivers of pathology.




